GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » HLS Therapeutics Inc (TSX:HLS) » Definitions » Other Noninterest Expense

HLS Therapeutics (TSX:HLS) Other Noninterest Expense


View and export this data going back to 1959. Start your Free Trial

What is HLS Therapeutics Other Noninterest Expense?

Other Noninterest Expense (Bank) only applys to banks.


HLS Therapeutics Business Description

Traded in Other Exchanges
Address
10 Carlson Court, Suite 701, Etobicoke, ON, CAN, M9W 6L2
HLS Therapeutics Inc is a specialty pharmaceutical company. It is focused on the acquisition and commercialization of branded pharmaceutical products in the North American markets. The company products include Clozaril, Vascepa, CSAN Pronto, and others. The company earns revenue in the form of product sales and royalties, out of which product sales contribute to the majority of the revenue. The company operates in Canada, and the United States, and the Rest of the world.
Executives
Norma Beauchamp Director
Craig Millian Director, Senior Officer
Brian Thomas Walsh Senior Officer
Polar Asset Management Partners Inc. 10% Security Holder
John Gordon Hanna Director, Senior Officer
Athyrium Opportunities Ii Co-invest 1 Lp 10% Security Holder
Jr. John Lee Welborn Director
Tim Hendrickson Senior Officer
William M. Wells Director, Senior Officer
Gilbert Godin Director, Senior Officer
Gregory David Gubitz Director
Orbimed Advisors Llc 10% Security Holder
Jason Gross Senior Officer
Ryan Christopher Lennox Senior Officer